According to the current analysis of Reports and Data, the ELISpot and Fluorospot Assay Market was valued at USD 123.5 million in 2018 and is expected to reach USD 408.8 million by the year 2026, at a CAGR of 15.9%. ELISpot, also known as Enzyme-linked immune absorbent spot and Fluorospot, are assay methods used to detect cytokine secretion in samples, including blood plasma, serum, tissues, and others. The technique is antibody-based, wherein the microplates used in the assay are covered by specific antibodies that detect significant proteins from the sample. The ELISpot and Fluorospot are used on a regular basis in various research institutes for cytokine detection and analysis secreted by single cells.
The rise in the research and development in the vaccines sector is expected to drive the market majorly. Rising prevalence of infectious diseases that can be detected using ELISpot and Fluorospot assay methods is also a driving factor for the market. For instance, according to the estimates given by the World Health Organization (WHO), around 30 new diseases have emerged in the last 20 years, and now these diseases threaten the health of millions of people in the world. Moreover, the epidemics of infectious diseases worldwide affect around 3 to 5 million people annually and cause severe illness. Various companies have invested in the R&D sector to improve the assay techniques and to gain reliable results. Moreover, the rising cases of chronic disorders and increasing awareness about the diagnosis of chronic diseases are expected to propel the demand extensively. There is a significant increase in healthcare expenditure in developing countries, which could contribute to the growth of the industry.
North America dominates the ELISpot and Fluorospot market owing to the increasing number of manufacturers, spread of infectious diseases, improved health care infrastructure, and the development of various new products. Increasing the production of innovative products and the growth of manufacturers in their countries has led Europe to progress its global presence in the ELISpot and FluoroSpot industry supported by mergers and acquisitions that are increasing the global presence of European markets.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2697
The report provides a panoramic view of the market and insights that will help formulate better business decisions. In addition to that, the study helps well-established companies and players gain a deeper understanding of the market and make informed decisions. The report also discusses in detail about the key factors influencing the market growth.
Key companies operating in the market include:
Oxford Immunotec, Cellular Technologies, Mabtech, Becton, Dickinson and Company, Abcam, Bio-Techne, U-Cytech Biosciences, Lophius Biosciences GmbH, and Biotech Investissement Group.
The report covers an extensive analysis of the key market players in the market along with their business overview, expansion plans, and strategies. The report also focuses on recent strategic alliances in the market including mergers and acquisitions, joint ventures, partnerships, agreements, corporate and government deals, product launches, and brand promotions, among others.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2697
The report aims to provide a better understanding of the market dynamics and the workings of the industry on a global level. To gain a deeper understanding of the industry, the global ELISpot and Fluorospot Assay market is further segmented on the basis of key geographical regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. The report also offers a country-wise analysis to provide crucial insights into market size, market growth, market revenue growth, and economic growth in each region.
On basis of product types and application offered by the ELISpot and Fluorospot Assay industry, the market is segmented into:
By Product (Revenue in Million USD; 2016–2026)
- Assay Kits
- B cell assay
- T cell assay
- Ancillary products
By Application (Revenue in Million USD; 2016–2026)
- Infectious diseases
- Clinical trials
By End Use (Revenue in Million USD; 2016–2026)
- Research Institutes
- Diagnostic Centers
- Hospital and clinics
- Ambulatory surgical centers
The regional analysis covers:
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
To know more about the report @ https://www.reportsanddata.com/report-detail/elispot-and-fluorospot-assay-market
Benefits of ELISpot and Fluorospot Assay Market Report:
- Panoramic overview of the opportunities and risks in the ELISpot and Fluorospot Assay sector
- Study of recent innovations and developments in the industry
- Comprehensive study of the growth pattern of the ELISpot and Fluorospot Assay industry
- In-depth assessment of the competitive landscape of the key players of the ELISpot and Fluorospot Assay industry
- Analysis of the ELISpot and Fluorospot Assay market drivers, constraints, and opportunities
- Assessment of technological developments and latest trends of the industry
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2697
Thank you for reading our report. For customization or further inquiry, please get in touch with us. Our team will ensure the report is tailored according to your requirements.
Browse More Reports :
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]